MQS Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,818
| Closed | -$561K | – | 457 |
|
|
2024
Q2 | $561K | Buy |
+6,818
| New | +$561K | 0.34% | 87 |
|
|
2023
Q4 | – | Sell |
-4,015
| Closed | -$355K | – | 472 |
|
|
2023
Q3 | $355K | Buy |
4,015
+115
| +3% | +$10.2K | 0.22% | 200 |
|
|
2023
Q2 | $338K | Sell |
3,900
-357
| -8% | -$30.9K | 0.23% | 177 |
|
|
2023
Q1 | $414K | Buy |
+4,257
| New | +$414K | 0.27% | 141 |
|
|
2022
Q3 | – | Sell |
-4,374
| Closed | -$362K | – | 421 |
|
|
2022
Q2 | $362K | Sell |
4,374
-678
| -13% | -$56.1K | 0.25% | 169 |
|
|
2022
Q1 | $390K | Buy |
+5,052
| New | +$390K | 0.32% | 125 |
|